Peptides for Post-surgical recovery in Dogs
The short answer
For post-surgical recovery in dogs, the compounds under investigation are BPC-157, TB-500, GHK-Cu, MGF — of which BPC-157 has the strongest evidence base, graded emerging. Supporting tissue repair, comfort, and return to function after an orthopaedic or soft tissue procedure. No compound described here is FDA-approved for this use in dogs, and none should be started without veterinary involvement.
About the condition
The weeks after surgery determine how well a repair holds and how much function returns. The limiting factors are usually blood supply to the repair site, inflammation control, and preserving muscle during the enforced rest period. This is the most common reason owners look into peptides for dogs, and it is also where the risk of doing harm is lowest — provided the protocol supports the surgeon's plan rather than tempting an early return to activity. Nothing here substitutes for restricted exercise and structured rehabilitation.
Compounds investigated for this condition
Ranked by strength of the published evidence.
The only peptide on this site with published canine pharmacokinetic data.
BPC-157 is a short chain of fifteen amino acids originally identified in gastric juice. Research describes it encouraging the growth of new blood vessels into damaged tissue, which is the rate-limiting step in most healing. Studies also report a protective effect on the lining of the gut. It is the one compound here with a published pharmacokinetic study performed in dogs, which is why it appears first on almost every canine protocol.
Full BPC-157 profile, dosing and safety →The most established compound in veterinary research, with equine work dating to the early 2000s.
TB-500 is a synthetic fragment of thymosin beta-4, a protein found naturally throughout the body and concentrated at wound sites. The active portion binds actin, the structural protein cells use to move. Research describes this helping repair cells migrate into damaged tissue, alongside new blood vessel formation and collagen laydown.
Full TB-500 profile, dosing and safety →A copper-binding tripeptide with a published canine wound-healing study.
GHK-Cu is a three-amino-acid peptide bound to copper, found naturally in blood plasma at levels that decline with age. Research describes it influencing the expression of several thousand genes involved in tissue remodelling, which is why it appears in both wound-healing and skin and coat contexts. It is one of the few compounds here with a canine study behind it.
Full GHK-Cu profile, dosing and safety →A locally acting muscle-repair peptide injected near the site of injury.
MGF is a splice variant of the IGF-1 gene that muscle produces in response to mechanical loading and damage. Its half-life is extremely short — around fifteen minutes — which means it acts where it is placed. That is why protocols call for injecting close to the injured muscle rather than anywhere convenient.
Full MGF profile, dosing and safety →Critical safety notes
These apply to the compounds listed above and should be read before considering any of them.
⚠ TB-500: Contraindicated with active cancer
TB-500 is associated with promoting angiogenesis and cell migration in preclinical models — the same two processes tumours depend on to grow and spread. Any dog with a known or suspected malignancy should be screened and cleared before this compound is considered.
⚠ GHK-Cu: Copper storage disease in predisposed breeds
Bedlington Terriers and certain Labrador Retriever lines carry an inherited copper storage disorder. In these dogs the injectable route risks hepatic copper accumulation. Hepatic function must be monitored, and the topical route is strongly preferred.
⚠ MGF: Contraindicated with active cancer
As an IGF-1 family growth factor, MGF promotes cell proliferation. It should not be used in a dog with known or suspected malignancy.
Common questions
What peptides are used for post-surgical recovery in dogs?+
BPC-157, TB-500, GHK-Cu, MGF are the compounds investigated for post-surgical recovery in dogs. BPC-157 carries the strongest evidence of these, graded as emerging evidence. None are FDA-approved for this use in dogs.
Do peptides actually help post-surgical recovery in dogs?+
The honest answer is that the canine evidence is limited. Supporting tissue repair, comfort, and return to function after an orthopaedic or soft tissue procedure. The compounds investigated here have mechanistic support and, in some cases, published animal data — but controlled clinical trials in dogs with post-surgical recovery have not been conducted. Any use is investigational and belongs in a conversation with your veterinarian rather than a decision made independently.
References
- 1.CANINE STUDYHe L, et al. Pharmacokinetics, distribution, metabolism and excretion of BPC 157 in rats and dogs. Frontiers in Pharmacology, 2022. PMID 36588722
- 2.CANINE STUDYXu C, et al. Preclinical safety evaluation of body protective compound-157. Regulatory Toxicology and Pharmacology, 2020. PMID 32334036
- 3.Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. Orthopaedic Journal of Sports Medicine, 2025. PMC12313605
- 4.Gwyer D, Wragg NM, Wilson SL Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 2019. PMID 30915550
- 5.Jozwiak M, et al. Multifunctionality of BPC 157: Literature and Patent Review. Pharmaceuticals, 2025. PMC11859134
- 6.CANINE STUDYJournal of the American Holistic Veterinary Medical Association Case report: canine stifle injury managed with BPC-157 and TB-500. JAHVM, 2023. View source
- 7.Kleinman HK, Sosne G Thymosin beta 4 promotes dermal healing: animal studies. Annals of the New York Academy of Sciences, 2010. PMID 20536453
- 8.Goldstein AL, Hannappel E, Sosne G, Kleinman HK Thymosin beta-4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 2012. PMID 22074294
- 9.Kwok WH, et al. Doping control analysis of TB-500 in equine urine and plasma. Journal of Chromatography B, 2013. PMID 23084823
- 10.Esposito S, et al. TB500/TB1000: understanding misbranded drugs. Drug Testing and Analysis, 2022. View source
- 11.CANINE STUDYCanapp SO, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Veterinary Surgery, 2003. PMID 14569578
- 12.Maquart FX, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex in rat experimental wounds. Journal of Clinical Investigation, 1993. PMID 8227350
- 13.Pickart L, Vasquez-Soltero JM, Margolina A GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International, 2015. PMC4508379
- 14.Pickart L, Margolina A Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences, 2018. PMC6073405
- 15.Goldspink G Mechanical signals, IGF-I gene splicing, and muscle adaptation. Physiology, 2005. PMID 16174871
Where to source research peptides
Compound quality is the variable most owners underestimate. Purity, accurate peptide content, and correct labelling determine whether any published dosing figure means anything at all. Pet & Peps Research publishes third-party testing on the compounds covered in this guide and supports this site.
Educational information — not veterinary medical advice
Everything on this page is compiled from published peer-reviewed literature for educational and research purposes. It does not establish a veterinarian-client-patient relationship (VCPR) and is not a substitute for veterinary examination and diagnosis. Most compounds described here are investigational or used off-label and are not FDA-approved for these purposes in dogs. Extralabel drug use in animals requires a valid VCPR and the direct supervision of a licensed veterinarian under AMDUCA (21 U.S.C. §360b). Dosing figures are reported as they appear in the source literature and are not recommendations.